Research - Initial Experience of Intravesical Gemcitabine for Patients With High-Risk Superficial Transitional Cell Carcinoma Of the Bladder Following BCG Failure
Identification:
unj_ma14_05
Issue:
March-April 2014
Volume:
Volume 34 Number 2
Overview
Comments
Author(s):
Paula Allchorne
,
MBA
James S. Green
,
LLM, FRCS (Urol.)
Speaker(s):
Janette Kinsella
,
MSc, ANP
Benjamin W. Lamb
,
PhD, MRCS
Jonathan Shamash
,
MD, MRCP, MBChB
Credits
Credits: None available.
You must be logged in and own this product in order to post comments.
×
References